Patent · US Expired

Implantable prosthetic device for implantation into a human patient having a surface treated with microvascular endothelial cells

US5230693A · kind A · utility

62Cited by
1References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 27, 1991
Grant dateJul 27, 1993
Priority date
Expiry dateJun 27, 2011

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L27/38
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

The present invention provides a synthetic or naturally occurring implant, such as a vascular graft, for implantation into a human patient. Uncultured, microvascular endothelial cells, isolated from microvascular endothelial cell rich tissue are disposed on at least one surface of the implant to provide at least about 50% confluence of the cells on the surface of the implant prior to implantation. In a preferred embodiment, the microvascular endothelial cells are obtained from fat tissue. Because of the large number of fresh microvascular endothelial cells that may be obtained from such tissue, sufficient cells may be placed on the implant so that they attach to provide at least 50% confluent coverage of the implant surface prior to the time of implantation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.